|
-
Stroke is the first killer of people's life and health. It has the characteristics of high morbidity, high fatality rate, high disability rate, high recurrence rate and high economic burden.So what exactly is stroke? How did it come about? How can we prevent it correctly? This article takes you to understand in detail.01 Correct understanding of strokeIn medicine, cerebrovascular diseases can be divided into acute and chronic diseases, among which acute cerebrov
-
01 What is a stroke?Stroke, also known as cerebrovascular accident stroke, is an acute vascular disease that damages the brain tissue due to insufficient blood supply to the brain tissue due to cerebral vascular obstruction or rupture of the cerebral blood vessels.It has the characteristics of high morbidity, high mortality, high disability rate, high recurrence rate and high economic burden.According to the World Health Organization, 1 in 6 people in the
-
On May 10, Rebiosun (Zhejiang) Pharmaceutical Co., Ltd. signed an equity investment agreement with Hangzhou Shuimu Fenghua Venture Capital Partnership, a subsidiary of Zhejiang Tsinghua Yangtze River Delta Research Institute Hangzhou Branch. Hangzhou Shuimu Fenghua invested in Rebiosun (Zhejiang) Pharmaceutical Co., Ltd. , become a shareholder of the company.Zhejiang Tsinghua Yangtze River Delta Research Institute is the forerunner of Zhejiang's strategy of introducing famous universities an
-
The signing ceremony of the class 1 innovative drug project for angiogenesis, which was developed by Rebiosun Pharma, was held in the conference room of Dongyang Administrative Center a few days ago.Lou Langjian, Deputy Secretary of Dongyang Municipal Party Committee and Mayor, attended the signing ceremony and delivered a speech. Chen Hong, Executive Deputy Mayor of Dongyang City, presided over the signing ceremony. Relevant leaders and representatives of investors participated.Dr. Li Ming, the
|
|